Skip to main navigation Skip to search Skip to main content

GABA B -GIRK2-mediated signaling in down syndrome

Nathan P. Cramer*, Tyler K. Best, Marcus Stoffel, Richard J. Siarey, Zygmunt Galdzicki

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

47 Scopus citations

Abstract

Down syndrome (DS) results from the presence of an extra copy of genes on the long-arm of chromosome 21. Aberrant expression of these trisomic genes leads to widespread neurological changes that vary in their severity. However, how the presence of extra genes affects the physiological and behavioral phenotypes associated with DS is not well understood. The most likely cause of the complex DS phenotypes is the overexpression of dosage-sensitive genes. However, other factors, such as the complex interactions between gene products as proteins and noncoding RNAs, certainly play significant roles contributing to the spectrum of severity. Here we will review evidence regarding how the overexpression of one particular gene encoding for G-protein-activated inward rectifying potassium type 2 (GIRK2) channel subunit and its coupling to GABA B receptors may contribute to a range of mental and functional disabilities in DS.

Original languageEnglish
Title of host publicationAdvances in Pharmacology
PublisherAcademic Press Inc.
Pages397-426
Number of pages30
EditionC
DOIs
StatePublished - 2010

Publication series

NameAdvances in Pharmacology
NumberC
Volume58
ISSN (Print)1054-3589

Keywords

  • Gene dosage
  • GIRK2 Knockout Trisomy 21
  • Hippocampus
  • Long-term potentiation
  • Mental retardation
  • Ts65Dn

Cite this